← Back to Search

Alpha-1 Blocker

Treatment for Erectile Dysfunction

N/A
Waitlist Available
Led By Allen D Seftel, MD
Research Sponsored by University Hospitals Cleveland Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial found that taking alfuzosin may improve sexual function in males who have both BPH and ED.

Eligible Conditions
  • Erectile Dysfunction
  • Benign Prostatic Hyperplasia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluate the medication on erection maintenance
Secondary outcome measures
Assess effect of Uroxatral on BPH and sexual function using questionnaires

Find a Location

Who is running the clinical trial?

University Hospitals Cleveland Medical CenterLead Sponsor
317 Previous Clinical Trials
340,251 Total Patients Enrolled
1 Trials studying Erectile Dysfunction
34 Patients Enrolled for Erectile Dysfunction
SanofiIndustry Sponsor
2,164 Previous Clinical Trials
3,514,974 Total Patients Enrolled
3 Trials studying Erectile Dysfunction
287 Patients Enrolled for Erectile Dysfunction
Allen D Seftel, MDPrincipal InvestigatorUniversity Urologists of Cleveland

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025